THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $730,831 | -19.2% | 84,685 | -3.1% | 0.00% | 0.0% |
| Q2 2023 | $904,465 | -47.9% | 87,388 | -45.4% | 0.00% | -50.0% |
| Q1 2023 | $1,735,382 | +54.3% | 159,943 | +59.6% | 0.00% | +100.0% |
| Q4 2022 | $1,124,525 | +54.7% | 100,225 | +39.9% | 0.00% | 0.0% |
| Q3 2022 | $727,000 | +12.5% | 71,620 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $646,000 | +3.5% | 71,238 | +9.0% | 0.00% | 0.0% |
| Q1 2022 | $624,000 | -14.8% | 65,348 | -1.4% | 0.00% | – |
| Q4 2021 | $732,000 | +41.9% | 66,261 | -4.9% | 0.00% | – |
| Q3 2021 | $516,000 | -43.3% | 69,653 | +11.1% | 0.00% | – |
| Q2 2021 | $910,000 | -8.6% | 62,722 | +28.4% | 0.00% | -100.0% |
| Q1 2021 | $996,000 | -10.4% | 48,834 | -21.9% | 0.00% | 0.0% |
| Q4 2020 | $1,111,000 | +67.3% | 62,519 | +39.0% | 0.00% | – |
| Q3 2020 | $664,000 | -72.0% | 44,985 | -60.2% | 0.00% | -100.0% |
| Q2 2020 | $2,373,000 | -27.0% | 113,052 | -19.7% | 0.00% | -33.3% |
| Q1 2020 | $3,252,000 | -15.2% | 140,725 | -5.0% | 0.00% | 0.0% |
| Q4 2019 | $3,836,000 | +126.0% | 148,141 | +70.0% | 0.00% | +200.0% |
| Q3 2019 | $1,697,000 | +375.4% | 87,165 | +298.4% | 0.00% | – |
| Q2 2019 | $357,000 | -63.6% | 21,877 | -49.5% | 0.00% | -100.0% |
| Q1 2019 | $981,000 | -1.6% | 43,279 | +11.0% | 0.00% | 0.0% |
| Q4 2018 | $997,000 | -9.1% | 38,981 | +16.1% | 0.00% | 0.0% |
| Q3 2018 | $1,097,000 | -1.6% | 33,583 | -31.7% | 0.00% | 0.0% |
| Q2 2018 | $1,115,000 | -16.2% | 49,184 | -10.3% | 0.00% | 0.0% |
| Q1 2018 | $1,330,000 | +3.5% | 54,849 | +19.0% | 0.00% | 0.0% |
| Q4 2017 | $1,285,000 | -36.6% | 46,092 | -22.2% | 0.00% | -50.0% |
| Q3 2017 | $2,027,000 | +48.6% | 59,211 | +72.9% | 0.00% | +100.0% |
| Q2 2017 | $1,364,000 | -5.6% | 34,237 | -12.8% | 0.00% | 0.0% |
| Q1 2017 | $1,445,000 | -3.9% | 39,246 | -16.8% | 0.00% | 0.0% |
| Q4 2016 | $1,503,000 | -64.4% | 47,188 | -59.5% | 0.00% | -75.0% |
| Q3 2016 | $4,227,000 | +51.5% | 116,630 | -5.2% | 0.00% | +33.3% |
| Q2 2016 | $2,791,000 | +42.8% | 123,022 | +18.3% | 0.00% | +50.0% |
| Q1 2016 | $1,955,000 | +12.8% | 103,979 | -1.6% | 0.00% | 0.0% |
| Q4 2015 | $1,733,000 | +55.0% | 105,715 | +3.9% | 0.00% | +100.0% |
| Q3 2015 | $1,118,000 | -34.1% | 101,703 | -22.0% | 0.00% | -50.0% |
| Q2 2015 | $1,697,000 | -15.7% | 130,352 | +12.4% | 0.00% | 0.0% |
| Q1 2015 | $2,012,000 | +19.4% | 116,003 | +2.7% | 0.00% | +100.0% |
| Q4 2014 | $1,685,000 | -21.4% | 112,964 | +21.3% | 0.00% | -50.0% |
| Q3 2014 | $2,145,000 | +16.8% | 93,152 | +61.7% | 0.00% | 0.0% |
| Q2 2014 | $1,836,000 | – | 57,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |